Loading viewer...
investor_presentation
Format: PDF investor_presentation
Nexien Biopharma is a discovery and R&D platform developing next-generation cannabinoid pharmaceuticals with advanced drug formulation and delivery systems. The company targets primary and adjunct therapies across multiple indications, positioning its formulations to outperform existing standard-of-care treatments.
investor_presentation
32 Pages
Hiab
investor_presentation
Duke Energy
Tessco Technologies Investor Presentation — May 2018
investor_presentationinvestor_presentation
41 Pages
TESSCO Technologies, Incorporated